Methylphenidate vs atomoxetine: personalized medicine in attention- deficit/hyperactivity disorder
- PMID: 23636880
- DOI: 10.1001/jamapsychiatry.2013.760
Methylphenidate vs atomoxetine: personalized medicine in attention- deficit/hyperactivity disorder
Comment on
-
Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.Arch Gen Psychiatry. 2012 Sep;69(9):952-61. doi: 10.1001/archgenpsychiatry.2011.2053. Arch Gen Psychiatry. 2012. PMID: 22945622 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
